Analyst firms · H.C. Wainwright · SMTI

H.C. Wainwright SMTI price target and rating history

Sanara MedTech Inc. (SMTI) · Health Care

H.C. Wainwright rates Sanara MedTech Inc. (SMTI) Neutral with a $35 price target, as of its latest action on Jul 30, 2026. It has published 3 rating actions on SMTI since December 2024, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$35
Median target, all firms
Too few
Actions on SMTI
3

H.C. Wainwright price target on SMTI

$51$43$3520252026
H.C. Wainwright price target on SMTI, each point a stated target, December 2024 to July 2026.

Every H.C. Wainwright rating on SMTI

How other firms rate SMTI

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
H.C. WainwrightNeutral$35Jul 30, 2026
Lake StreetBuy$32Apr 15, 2026

Questions about H.C. Wainwright and SMTI

What is H.C. Wainwright's price target for SMTI?
H.C. Wainwright's latest stated price target for Sanara MedTech Inc. (SMTI) is $35, from its action on Jul 30, 2026.
What is H.C. Wainwright's rating on SMTI?
H.C. Wainwright rates SMTI Neutral, a neutral rating, as of Jul 30, 2026.
When did H.C. Wainwright last change its view on SMTI?
On Jul 30, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $35.

All H.C. Wainwright ratingsSMTI news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.